Kolexia
Feugeas Olivier
Biologie médicale
Cmco
Schiltigheim, France
61 Activités
153 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies de von Willebrand Thrombasthénie Hémophilie A COVID-19 Hémorragie Afibrinogénémie Syndrome coronarien aigu Placenta accreta Obésité

Industries

A+A
46 collaboration(s)
Dernière en 2023
DIAGNOSTICA STAGO
19 collaboration(s)
Dernière en 2023
Zeste Research
18 collaboration(s)
Dernière en 2021
B3TSI
18 collaboration(s)
Dernière en 2023

Dernières activités

Apixaban for treatment of venous thromboembolism in an obese patient with Glanzmann thrombasthenia.
Research and practice in thrombosis and haemostasis   20 mai 2023
Placenta percreta management in a patient with a severe congenital hypofibrinogenemia.
Annales de biologie clinique   19 mai 2023
PO230 STRASBOURG EXPERIENCE WITH THE USE OF VONICOG ALFA TO PREVENT THE RISK OF BLEEDING IN CONGENITAL OR ACQUIRED VON WILLEBRAND DISEASE
16th Annual Congress of European Association for Haemophilia and Allied Disorders 2023, 7–10 February 2023, Manchester   05 février 2023
PO220 ACQUIRED VON WILLEBRAND SYNDROME (AVWS): A FRENCH MULTICENTER EXPERIENCE
16th Annual Congress of European Association for Haemophilia and Allied Disorders 2023, 7–10 February 2023, Manchester   05 février 2023
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia.
Transfusion medicine (Oxford, England)   07 septembre 2022
Expérience chirurgicale en cas de syndrome de Willebrand acquis : expérience Strasbourgeoise
83e CONGRÈS FRANÇAIS DE MÉDECINE INTERNE   01 décembre 2021
COVID-19 and Patients with Hemorrhagic Congenital Disease: Experience from Regional Heamophilia Treatment Center of Strasbourg (France)
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Global Octim® Shortage: Experience in Strasbourg
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Use of recombinant Von Willebrand factor during transcatheter aortic valve replacement in a patient with acquired von Willebrand syndrome.
Transfusion medicine (Oxford, England)   24 février 2021
Efficacy and safety of a recombinant Von Willebrand Factor treatment in patients with inherited Von Willebrand Disease requiring surgical procedures.
Haemophilia : the official journal of the World Federation of Hemophilia   06 février 2021